Dr. Manjula G. Ananthram, MD
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
600 Gresham Dr
Norfolk, VA 23507
Who else practices at this address →
Norfolk city is a federal dental shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 33
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 802
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
VA license 0101231760 -
Cardiovascular Disease Physician
NE license 23286 · VA license 0101231760
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- Sentara Norfolk General Hospital Norfolk, VA
- Sentara Leigh Hospital Norfolk, VA
- Sentara Virginia Beach General Hospital Virginia Beach, VA
- Sentara Obici Hospital Suffolk, VA
- Sentara Careplex Hospital Hampton, VA
Medical groups
- Sentara Medical Group (1,408 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 802
- Services billed
- 1,611
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 568 | 537 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 152 | 49 |
| Evaluation of lower heart chamber assist device | 135 | 29 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 118 | 41 |
| Established patient office or other outpatient visit, 40-54 minutes | 116 | 72 |
| Critical care, first 30-74 minutes | 106 | 30 |
| Established patient office or other outpatient visit, 30-39 minutes | 76 | 52 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 19 | 18 |
| Ultrasound of heart, follow-up | 16 | 16 |
| New patient office or other outpatient visit, 60-74 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Spironolactone Other prescribers in Norfolk, VA | 85 |
| Metoprolol Succinate Other prescribers in Norfolk, VA | 65 |
| Jardiance (empagliflozin) Other prescribers in Norfolk, VA | 62 |
| Entresto (sacubitril/valsartan) Other prescribers in Norfolk, VA | 47 |
| Furosemide Other prescribers in Norfolk, VA | 42 |
| Atorvastatin Calcium Other prescribers in Norfolk, VA | 42 |
| Torsemide Other prescribers in Norfolk, VA | 34 |
| Xarelto (rivaroxaban) Other prescribers in Norfolk, VA | 27 |
| Hydralazine Hcl Other prescribers in Norfolk, VA | 26 |
| Amiodarone Hcl Other prescribers in Norfolk, VA | 24 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 13 payments worth $4,507 in total to this clinician.
| UCB, Inc. | $3,355 |
|---|---|
| Abbott Laboratories | $1,063 |
| Teleflex LLC | $59.76 |
| One Lambda, Inc. | $30.09 |
| Consulting Fee | $3,355 |
|---|---|
| Travel and Lodging | $652 |
| Food and Beverage | $501 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| UCB, Inc. Feb 18, 2025 | Consulting Fee | $3,355 |
| Abbott Laboratories Dec 1, 2025 | Travel and Lodging THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Structural Heart · travel to Norfolk, VA · in-kind | $385 |
| Abbott Laboratories Oct 10, 2025 | Travel and Lodging THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Structural Heart · travel to Miami, FL · in-kind | $229 |
| Abbott Laboratories Oct 11, 2025 | Travel and Lodging THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Structural Heart · travel to Miami, FL · in-kind | $29.05 |
| Abbott Laboratories Dec 1, 2025 | Travel and Lodging THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Structural Heart · travel to Norfolk, VA · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $48,279 in research payments for these studies, mostly to the institutions running them.
- PROACTIVE-HF
Endotronix, Inc. - A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic C…
E.r. Squibb & Sons, L.l.c. - PSR-MCS
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.